Dados B3Stocks › SAUD3 PT

Saúde

SAUD3 — BRADSAÚDE S.A.

CNPJ 58.119.199/0001-51 · listed classes: SAUD3, ODPV3 · CVM code 20125

13.7P/E
6.2P/B
9.2EV/EBITDA
6.3%FCF yield
46.4%ROE 2025
58.9%ROIC 2025
P/E, P/B and EV/EBITDA priced at the session of 2026-02-27 (R$ 14.64), the first one after the 2025 filing became public on 2026-02-27 — point-in-time, not the 31 December price.

The full history, year by year

The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.

indicator2010201120122013201420152016201720182019202020212022202320242025
ROE 30.5%!19.6%19.9%27.0%29.1%34.2%32.1%62.2%29.2%26.6%31.2%32.8%39.3%39.8%41.2%46.4%
ROIC 19.7%!23.2%26.3%39.0%45.2%59.8%67.7%102.3%51.4%48.3%68.4%56.2%45.9%51.9%58.9%
ROA 24.0%!15.3%14.6%18.2%17.9%19.2%16.9%36.6%18.8%16.7%19.5%19.8%22.8%24.5%25.2%28.6%
Gross margin 50.5%50.1%49.2%53.1%52.5%53.4%50.8%72.5%55.8%55.2%59.6%60.3%61.5%30.9%34.3%36.0%
EBIT margin 16.6%21.5%20.9%24.6%23.7%24.7%20.6%40.1%24.0%21.4%29.2%27.6%30.2%30.1%31.9%
Net margin 31.4%17.4%15.3%17.6%16.9%17.7%15.8%35.0%17.9%15.7%20.4%20.7%23.7%24.1%23.6%24.1%
Revenue growth (1y) 19.7%14.4%11.9%8.1%8.1%9.2%5.3%10.8%13.6%-2.4%4.4%3.3%14.3%7.7%6.1%
Revenue growth (5y CAGR) 12.4%10.3%8.5%8.3%9.4%7.2%6.2%5.8%5.9%4.7%6.5%
Net debt/EBITDA -1.09x-1.12x-1.06x-0.96x-0.95x-1.06x-1.48x-0.75x-1.21x-1.32x-1.35x-0.58x-0.38x-0.50x-0.35x
Current ratio 1.35x1.88x1.66x1.68x1.59x1.73x1.89x1.47x1.36x1.64x1.81x0.98x0.70x0.80x0.64x0.80x

The current year, quarter by quarter

As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.

quarterrevenueprofitnet marginP/E TTMP/Bfiled on
2024T1554.5146.726.5%13.04.532024-05-07
2024T2570.3130.022.8%11.64.932024-08-06
2024T3570.4147.825.9%11.74.952024-11-05
2025T1587.8169.628.8%10.24.222025-05-06
2025T2603.7147.824.5%11.65.192025-08-05
2025T3617.4142.423.1%12.15.402025-11-04
2026T1614.6152.124.8%14.55.722026-05-04
2026T28,096.9636.47.9%44.62.512026-08-03

Full series, every quarter: GET /empresas/SAUD3/trimestres

Dividends per year

yearper sharepayments
2026R$ 0.07871
2025R$ 0.96228
2024R$ 1.44669
2023R$ 0.36655
2022R$ 0.31366
2021R$ 0.47186
2020R$ 0.50628
2019R$ 0.36048

Piotroski F-Score 8/9 (2025) — what each criterion means.

Restated filings for this company

The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.

fiscal yearaccountfirst filingrestated
2022DRE 3.031,150.3479.0
2022DRE 3.02-726.4-1,346.4
2022BPA 1.01424.5259.8
2022BPA 11,970.31,835.5
2022BPP 21,970.31,835.5
2022DRE 3.07636.6505.1
2022DMPL 5.05452.3338.0
2022DRE 3.05566.1469.6

This company appears in

Other companies in Healthcare

15 more with a page, same CVM sector — a classification of the regulator's, not ours.

Take this into your code

Everything on this page is also JSON: GET /empresas/SAUD3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).

Price coverage: 4,137 sessions, 2010-01-04 → 2026-09-04 · methodology · how we verify

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 10:36 UTC. If this does not match /saude, you are reading a cached copy.